Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2004 Mar;83(3):272-5.
doi: 10.1111/j.0001-6349.2004.0141.x.

The efficacy low dose of prednisolone in the treatment of hyperemesis gravidarum

Affiliations
Clinical Trial

The efficacy low dose of prednisolone in the treatment of hyperemesis gravidarum

Saeideh Ziaei et al. Acta Obstet Gynecol Scand. 2004 Mar.

Abstract

Background: To determine whether low dosages of prednisolone are effective in the treatment of outpatients with hyperemesis gravidarum.

Methods: Eighty pregnant women with gestational ages of 6 to 12 weeks and persistent nausea and vomiting participated. The women were assigned by simple randomization to receive prednisolone 5 mg daily or promethazine 75 mg daily by oral route for 10 days. The severity of nausea, frequency of vomiting per day, sickness and the drugs' side-effects were compared (Fisher's exact test, Mann-Whitney U-test, Odds Ratio test).

Results: The women who received promethazine responded better in the first 48 h (p = 0.02). With continuation of the treatment, the difference decreased, and one week after completion of the treatment, the subjects who had received prednisolone had less symptoms.

Conclusion: Promethazine reduces the symptoms of hyperemesis gravidarum faster than prednisolone, but during prolonged treatment, prednisolone has at least the same effects on the symptoms and less drug side-effects.

PubMed Disclaimer

MeSH terms